It also significantly reduced their food intake and their cumulative weight gain and improved glucose tolerance without changing insulin secretion [ 141 ]
But beneath the glossy marketing and viral before-and-afters lies a troubling reality: Americas GLP-1 boom has created a sprawling, barely regulated industry filled with legal gray zones, foreign manufacturing concerns, and counterfeit products that could put patients at serious risk
A 12-month interventional study demonstrates the beneficial effects of semaglutide, both oral and subcutaneous, on body weight, insulin resistance, liver function, lipid profile, and hepatic steatosis
Although in databases such as Global DRO and NADAmed this substance had a prohibited-in-competition status, WADA only confirmed this in 2024, placing midodrine among the examples of class S6 stimulants on the 2025 List of Prohibited Substances and Methods [1]